GT
PBH icon

Glenmede Trust’s Prestige Consumer Healthcare PBH Stock Holding History

Glenmede Trust’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.6M Sell
212,461
-19,814
-9% -$1.29M 0.06% 276
2025
Q4 		$14.3M Buy
+232,275
New +$14.2M 0.07% 248
2025
Q1 		$23.6M Sell
273,967
-8,873
-3% -$728K 0.13% 150
2024
Q4 		$22.1M Sell
282,840
-2,001
-0.7% -$155K 0.11% 171
2024
Q3 		$20.5M Sell
284,841
-3,715
-1% -$263K 0.1% 201
2024
Q2 		$19.9M Sell
288,556
-660
-0.2% -$44.7K 0.1% 200
2024
Q1 		$21M Buy
289,216
+20,788
+8% +$1.39M 0.11% 194
2023
Q4 		$16.4M Sell
268,428
-5,345
-2% -$317K 0.09% 236
2023
Q3 		$15.7M Sell
273,773
-4,808
-2% -$291K 0.09% 231
2023
Q2 		$17.4M Buy
278,581
+532
+0.2% +$31.8K 0.1% 217
2023
Q1 		$17.4M Buy
278,049
+3,248
+1% +$203K 0.1% 218
2022
Q4 		$17.2M Sell
274,801
-32,170
-10% -$1.84M 0.1% 219
2022
Q3 		$15.3M Sell
306,971
-37,153
-11% -$2.06M 0.1% 231
2022
Q2 		$20.2M Sell
344,124
-37,361
-10% -$2.06M 0.12% 192
2022
Q1 		$20.2M Sell
381,485
-4,123
-1% -$238K 0.1% 239
2021
Q4 		$23.4M Sell
385,608
-2,887
-0.7% -$171K 0.11% 211
2021
Q3 		$21.8M Sell
388,495
-4,636
-1% -$255K 0.11% 209
2021
Q2 		$20.5M Sell
393,131
-959
-0.2% -$46.1K 0.11% 219
2021
Q1 		$17.4M Sell
394,090
-104,756
-21% -$4.4M 0.09% 240
2020
Q4 		$17.4M Sell
498,846
-42,820
-8% -$1.52M 0.1% 248
2020
Q3 		$19.7M Buy
541,666
+124,483
+30% +$4.63M 0.12% 197
2020
Q2 		$15.7M Buy
417,183
+414,203
+13,899% +$16.6M 0.1% 250
2020
Q1 		$120K Hold
2,980
– – ﹤0.01% 1360
2019
Q4 		$120K Buy
2,980
+80
+3% +$2.98K ﹤0.01% 1360
2019
Q3 		$100 Buy
2,900
+181
+7% +$5.96K ﹤0.01% 1407
2019
Q2 		$86 Sell
2,719
-19
-0.7% -$565 ﹤0.01% 1455
2019
Q1 		$81 Sell
2,738
-33
-1% -$946 ﹤0.01% 1472
2018
Q4 		$85 Buy
+2,771
New +$101K ﹤0.01% 1410
2018
Q3 		– Sell
-300
Closed -$12K – 1720
2018
Q2 		$12K Buy
300
+217
+261% +$7.32K ﹤0.01% 1849
2018
Q1 		$3K Hold
83
– – ﹤0.01% 2525
2017
Q4 		$3K Sell
83
-2,959
-97% -$135K ﹤0.01% 2525
2017
Q3 		$152K Buy
3,042
+2,959
+3,565% +$151K ﹤0.01% 1315
2017
Q2 		$4K Hold
83
– – ﹤0.01% 2346
2017
Q1 		$4K Buy
83
+49
+144% +$2.7K ﹤0.01% 2346
2016
Q4 		$1K Sell
34
-85
-71% -$4.1K ﹤0.01% 2422
2016
Q3 		$5K Hold
119
– – ﹤0.01% 2274
2016
Q2 		$6K Buy
+119
New +$6.55K ﹤0.01% 2203
2015
Q3 		– Sell
-103
Closed -$4K – 2792
2015
Q2 		$4K Buy
+103
New +$4.51K ﹤0.01% 2289

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Glenmede Trust's PBH Position: Q1 2026 in Review

Glenmede Trust reduced its Prestige Consumer Healthcare (PBH) stake by 8.5% in Q1 2026, selling an estimated $1.29M and leaving 212,461 shares worth $12.6M. The position accounts for 0.06% of the portfolio, ranked #276.

Glenmede Trust first reported a position in PBH in Q2 2015 and has held it in 38 quarters since. The position peaked at $23.6M in Q1 2025. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.

  • Glenmede Trust held 212,461 shares of Prestige Consumer Healthcare worth $12.6M as of Q1 2026.
  • Glenmede Trust sold 19,814 Prestige Consumer Healthcare shares in Q1 2026, an estimated $1.29M.
  • Prestige Consumer Healthcare made up 0.06% of Glenmede Trust's portfolio in Q1 2026, its #276 holding.
  • Glenmede Trust first reported a position in Prestige Consumer Healthcare in Q2 2015 and has held it in 38 quarters since.
  • Glenmede Trust's Prestige Consumer Healthcare position peaked at $23.6M in Q1 2025.
  • 355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.